Highly Potent Active Pharmaceuticals Ingredients

October 21-22, 2019 | USA

SMi is delighted to announce its Highly Potent Active Pharmaceutical Ingredients conference coming to Boston on the 21st - 22nd October 2019. The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure worker safety.

Spotlight

Handheld Raman is an attractive ID method because it provides a portable measurement that can distinguish different concentrations of active pharmaceutical ingredients (API) in drug product (DP) doses and placebos with little or no sample preparation.


OTHER PAST CONFERENCES

19th Annual Pharma Data Congress

September 8-9, 2022 | UK

Showcasing success in FAIR data implementation, data analytics in drug discovery, AI/ML technologies, RWE management, data storage & infrastructure, multi-omic data integration and management

Pharma Manufacturing And Automation

November 15, 2022 | USA

Join over 300 senior representatives across two days of cutting-edge presentations on the biggest issues and opportunities in drug product manufacturing and digital transformation.

18th BIOSIMILAR MEDICINES CONFERENCE

October 6-7, 2022 | USA

During this in-person event, speakers and panellists will explore how to turn the Pharmaceutical Strategy aim to ensure better access and affordability into concrete biosimilar medicine policy measures.

THE WORLDS LEADING PHARMA EVENT

November 1-3, 2022 | Germany

CPHI Frankfurt is the largest pharma event of the year. Join thousands of pharma professionals and industry experts from across the entire supply chain to grow your knowledge and expand your network.

Spotlight

Handheld Raman is an attractive ID method because it provides a portable measurement that can distinguish different concentrations of active pharmaceutical ingredients (API) in drug product (DP) doses and placebos with little or no sample preparation.

resources